Considerations for Development & Commercialization of Peptide Products
Time: 4:00 pm
day: Day Two
Details:
- Managing the evolution of dosage forms from early to late-stage development
- Understanding the implications of chemical and physical stability throughout the development program
- Evolving a target product profile (TPP) through the development program
- Using a novel formulation platform to achieve better TPP
